ARCHIVES

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

This article is from The Cancer Letter archive.

Vol. 20 No. 42 | November 4, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

Cholesterol-Lowering Drugs May Prevent Breast Cancer

October 31, 2003

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009